We want to cure every child with cancer and offer them the best possible quality of life during treatment — free from acute side effects such as nausea or fatigue — and to ensure they can thrive once treatment is completed, without long-term consequences such as learning difficulties or amputations.
KickCancer contributes in two ways:
1. We fund clinical trials: these studies give children access to innovative drugs in a safe and ethical environment, ensuring that treatments continue to improve for future patients.
2. We fund fundamental and translational research: such projects deepen our understanding of how paediatric cancers develop and behave. In the long run, they can lead to the development of new drugs and help identify specific subgroups of patients.
FIGHT KIDS CANCER: KickCancer finances innovative research projects in Europe
Because - fortunately - each paediatric cancer is a very rare disease, KickCancer chooses to support only the best research projects with a European scope, which is the only way to guarantee a satisfactory recruitment of patients.
In order to select the best projects, we have set up a watertight selection process together with other European organisations, Imagine for Margo (France), the Kriibskrank Kanner Fondatioun (Luxembourg), CRIS Cancer Foundation (Spain), KiKa (the Netherlands): the FIGHT KIDS CANCER annual call for European projects.
Discover our FIGHT KIDS CANCER projects
BSPHO : KickCancer collaborates with the Belgian physicians to ensure access to international clinical trials for Belgian patients
In Belgium, most young patients are treated within the framework of a clinical trial and this from the diagnosis. These are in most instances late-phase clinical trials.
The clinical trials' protocols are defined at the European level, but the financing of the projects often has to be sought by each participating country or site.
In Belgium, the Belgian Society for Paediatric Haemato-Oncology (BSPHO) coordinates and initiates the participation of the Belgian centres in international academic clinical trials. These trials ensure access to the best care for young patients treated in Belgium and a sustained participation of our oncology centres in the European research effort.
Discover our collaboration with the BSPHO
Clinical Trial Investigation Grant with the FNRS & FWO
To support the participation of Belgian paediatric haemato-oncologists in the development of future clinical trials for children with cancer in Europe, KickCancer has set up a new funding opportunity for clinicians who work in paediatric oncology units.
These grants will free them from 50% of their clinical duties at the bedside of patients to collaborate with their European colleagues on clinical trials and translational projects. These renewable 2-year grants will first be awarded in June 2026 and will take effect in October.
In rare disease areas like paediatric haemato-oncology, enabling doctors to combine clinical and scientific work is crucial for improving both quality of care and clinical expertise.
These grants are awarded in collaboration with the Fonds National de la Recherche Scientifique (FNRS) and the Fonds voor Wetenschappelijk Onderzoek (FWO), which contribute their expertise to the organisation of an independent selection process.
Discover our collaboration with the FRNS & FWO
